Topic

Cigna

A collection of 1335 issues

How to Get Taltz (Ixekizumab) Covered by Cigna in Virginia: Complete Guide to Forms, Appeals, and Step Therapy

Answer Box: Getting Taltz (Ixekizumab) Covered by Cigna in Virginia Fastest Path to Approval: Have your dermatologist or rheumatologist submit Cigna's Taltz Prior Authorization Form electronically via CoverMyMeds or fax to 1-866-873-8279. Include documentation of your psoriasis/psoriatic arthritis diagnosis, failed trials with conventional therapies (like methotrexate for
6 min read

How to Get Evkeeza (evinacumab-dgnb) Covered by Cigna in California: Prior Authorization, Appeals, and Success Strategies

Quick Answer: Getting Evkeeza Covered by Cigna in California To get Evkeeza (evinacumab-dgnb) covered by Cigna in California for homozygous familial hypercholesterolemia (HoFH), you'll need prior authorization with genetic testing confirmation, documented failure of high-intensity statin plus ezetimibe, and (for ages 10+) a PCSK9 inhibitor trial. If denied,
5 min read

How to Get Gamifant (Emapalumab-lzsg) Covered by Cigna in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Cigna to Cover Gamifant in North Carolina Cigna requires prior authorization for Gamifant (emapalumab-lzsg) with specific documentation: confirmed HLH diagnosis (5 of 8 HLH-2004 criteria or genetic testing), evidence of conventional therapy failure/intolerance, and concurrent dexamethasone use. Submit through CoverMyMeds or call 1-800-882-4462 for urgent cases.
6 min read

How to Get Orkambi (lumacaftor/ivacaftor) Covered by Cigna in Georgia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Orkambi (lumacaftor/ivacaftor) Covered by Cigna in Georgia Eligibility: Patients ≥1 year old with cystic fibrosis and confirmed F508del homozygous mutation. Fastest path: Submit prior authorization with genetic test results showing F508del/F508del genotype, CF diagnosis documentation, and specialist prescription. First step today: Contact your CF specialist
6 min read

Renewing Takhzyro (Lanadelumab-Flyo) Approval with Cigna in Michigan: Timeline, Documentation, and Appeal Options

Answer Box: Renewing Takhzyro Coverage with Cigna in Michigan Cigna typically approves Takhzyro (lanadelumab-flyo) for up to 12 months, requiring reauthorization with documented treatment response. Start your renewal 30-45 days before expiration. Submit evidence of reduced HAE attack frequency or severity, along with prescription by an allergist/immunologist. If denied,
4 min read